The PhillyMedClub
journal

Two of the numbers behind the recent testosterone headlines don’t survive checking — and the symptom underneath them matters more than either.

Imaging confirms the volume loss is real. It does not confirm the drug is the reason — and the distinction matters less for treatment than the name suggests.

Why the pigment you noticed this month was years in the making, and which parts of the seasonal argument actually hold up.

A conference abstract, a patent holder reviewing his own invention, and a case of mistaken identity. A physician traces three peptide claims back to their sources.

Research presented at ASCO 2026 links GLP-1 medications to lower breast cancer incidence. A physician who prescribes them explains what the data supports and what it does not.

The TRAVERSE trial, the FDA panel, and the fertility conversation nobody’s having. A family medicine physician separates evidence from marketing.

It affects 15 million Americans. Most don’t know it’s treatable. Here’s what the clinical data says about Botox for excessive sweating.

The aesthetics industry has an honesty problem. A physician breaks down three viral trends and explains why complication rates are far higher than the industry admits.

What the SURMOUNT-5 trial actually showed, what’s changed with FDA compounding rules, and what I recommend.

Substitutions happen at med spas, dermatology offices and plastic surgery practices alike. Here is what the data shows and what to ask before you book.

Timing matters more than most people realize. Here’s which treatments are safe before summer and which should wait for fall.

Per-unit pricing, product comparisons, and red flags — from a physician who actually does the injecting.

It reaches through the dermis into the fat layer — which is why the settings that suit a face are wrong here.

One comes from your own blood. The other is manufactured in yeast and labelled for topical use only.

Not a beginner treatment and an upgrade — two different jobs, with very differently sized evidence behind them.

The same treatments women get — dosed and placed differently, for reasons that are anatomical rather than marketing.

It targets water, not pigment — which is why it can be used on skin tones that rule out IPL and ablative resurfacing.

Both run at a similar depth on the face. The real variable is heat — and the person setting it.